A citation-based method for searching scientific literature

Nicolai J Birkbak, Zhigang C Wang, Ji-Young Kim, Aron C Eklund, Qiyuan Li, Ruiyang Tian, Christian Bowman-Colin, Yang Li, April Greene-Colozzi, J Dirk Iglehart, Nadine Tung, Paula D Ryan, Judy E Garber, Daniel P Silver, Zoltan Szallasi, Andrea L Richardson. Cancer Discov 2012
Times Cited: 298



Christopher J Lord, Alan Ashworth. Science 2017
Times Cited: 1153




List of shared articles



Times cited


Aberrant Transcript Usage Is Associated with Homologous Recombination Deficiency and Predicts Therapeutic Response.
Hyeon Gu Kang, Haeun Hwangbo, Myung Ji Kim, Sinae Kim, Eun Ji Lee, Min Ji Park, Jae-Weon Kim, Byoung-Gie Kim, Eun-Hae Cho, Suhwan Chang,[...]. Cancer Res 2022
1

[Homologous recombination deficiency and PARP inhibitors in therapeutics].
Hélène Salaün, Mathilde Saint-Ghislain, Audrey Bellesoeur, Philippe Beuzeboc, Cindy Neuzillet, Véronique Diéras, Marc Henri Stern, Manuel Rodrigues. Bull Cancer 2022
0

Therapeutic Targeting of DNA Damage Response in Cancer.
Wonyoung Choi, Eun Sook Lee. Int J Mol Sci 2022
7

PARP inhibitors for metastatic castration-resistant prostate cancer: Biological rationale and current evidence.
Michał Bieńkowski, Bartłomiej Tomasik, Marcin Braun, Jacek Jassem. Cancer Treat Rev 2022
2

Homologous Recombination Deficiency: Concepts, Definitions, and Assays.
Mark D Stewart, Diana Merino Vega, Rebecca C Arend, Jonathan F Baden, Olena Barbash, Nike Beaubier, Grace Collins, Tim French, Negar Ghahramani, Patsy Hinson,[...]. Oncologist 2022
4

Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types.
Jan Budczies, Klaus Kluck, Susanne Beck, Iordanis Ourailidis, Michael Allgäuer, Michael Menzel, Daniel Kazdal, Lukas Perkhofer, Alexander Kleger, Peter Schirmacher,[...]. J Pathol Clin Res 2022
0

Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD).
E Rempel, K Kluck, S Beck, I Ourailidis, D Kazdal, O Neumann, A L Volckmar, M Kirchner, H Goldschmid, N Pfarr,[...]. NPJ Precis Oncol 2022
0

A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer.
Guan-Hua Su, Lin Jiang, Yi Xiao, Ren-Cheng Zheng, He Wang, Yi-Zhou Jiang, Wei-Jun Peng, Zhi-Ming Shao, Ya-Jia Gu, Chao You. Ann Surg Oncol 2022
1


Pathogenicity assessment of variants for breast cancer susceptibility genes based on BRCAness of tumor sample.
Reiko Yoshida, Taichi Hagio, Tomoko Kaneyasu, Osamu Gotoh, Tomo Osako, Norio Tanaka, Sayuri Amino, Noriko Yaguchi, Eri Nakashima, Dai Kitagawa,[...]. Cancer Sci 2021
3

Homologous recombination repair deficiency (HRD): From biology to clinical exploitation.
David Gonzalez, Albrecht Stenzinger. Genes Chromosomes Cancer 2021
6

Perspectives on PARP inhibitors as pharmacotherapeutic strategies for breast cancer.
Sun Young Oh, Shafia Rahman, Joseph A Sparano. Expert Opin Pharmacother 2021
2

Random Forest Modelling of High-Dimensional Mixed-Type Data for Breast Cancer Classification.
Jelmar Quist, Lawson Taylor, Johan Staaf, Anita Grigoriadis. Cancers (Basel) 2021
0

Evolutionary Trajectories and Genomic Divergence in Localized Breast Cancers after Ipsilateral Breast Tumor Recurrence.
Chia-Hsin Wu, Hsien-Tang Yeh, Chia-Shan Hsieh, Chi-Cheng Huang, Amrita Chattopadhyay, Yuan-Chiang Chung, Shih-Hsin Tu, Yung-Hua Li, Tzu-Pin Lu, Liang-Chuan Lai,[...]. Cancers (Basel) 2021
1

A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures.
Miklos Diossy, Zsofia Sztupinszki, Judit Borcsok, Marcin Krzystanek, Viktoria Tisza, Sandor Spisak, Orsolya Rusz, Jozsef Timar, István Csabai, Janos Fillinger,[...]. NPJ Precis Oncol 2021
4